Search

Search Results
Results 7721 - 7730 of 8412 for allergy
  • Buscopan Injection
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan Injection intended for persons living in Australia.
  • Buscopan Forte
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan Forte intended for persons living in Australia.
  • Zatamil
    Drug - 1 Nov 2020
    Consumer Medicine Information (CMI) about Zatamil intended for persons living in Australia.
  • Identifying Illegal Food Products Using Chromatography
    Life Sciences - 22 Oct 2020
    Significant steps are being taken to made food items safer, which has led to an increasing number of ingredients being banned from use in products.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Orfadin Oral Suspension
    Drug - 21 Sep 2020
    Consumer Medicine Information (CMI) about Orfadin Oral Suspension (Nitisinone) intended for persons living in Australia.
  • Cyprone 50
    Drug - 7 Sep 2020
    Consumer Medicine Information (CMI) about Cyprone 50 (contains cyproterone acetate) intended for persons living in Australia.
  • Risperdal Consta
    Drug - 11 Aug 2020
    Consumer Medicine Information (CMI) about Risperdal Consta (Risperidone) intended for persons living in Australia.
  • Modafinil Mylan
    Drug - 19 Jun 2020
    Consumer Medicine Information (CMI) about Modafinil Mylan (Modafinil) intended for persons living in Australia.
  • Temozolomide Alphapharm
    Drug - 4 May 2020
    Consumer Medicine Information (CMI) about Temozolomide Alphapharm (Temozolomide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback